November 29, 2009 — A second-generation CR-based Full Field Digital Mammography (FFDM) marks the evolution of the only FDA-approved CR-based mammography solution available in the United States, according to the company.

The new system, called Aspire ClearView, delivers the same exceptional image quality as before with enhanced features and an upgraded technologist workstation.

The system’s enhancements include a sleeker design, lighter weight and a wider viewing angle on the LCD offering additional flexibility for room placement. ClearView will continue to be offered in a single slot and four-slot design. ClearView remains the only approved FFDM that can perform general x-ray imaging.

The latest evolution of the Aspire ClearView workstation, the AWS-c, will be the first color workstation available for technologists. This new workstation offers technologists an improved graphic user interface (GUI) with a full color, high brightness, 2 mega pixel LCD monitor in portrait format for quick recognition of important patient and exposure information.

A user-friendly technologist GUI will be available with both the AWS-c and the AWS-d, the workstation that will be paired with Fujifilm’s new Aspire HD2, DR-based FFDM system. This will provide consistency across product lines for a streamlined workflow and greater efficiency for the user of either of Fujifilm’s FFDM offerings. Also available for the first time is an optional high resolution, 3 mega pixel or 5 mega pixel, greyscale companion monitor for quick confirmation of the acquired image.

The new Aspire ClearView readers are expected to be available in the first half of 2010. The AWS-c will be commercially available upon receipt of pending FDA approval.

For more information: www.fujimed.com.


Related Content

News | Breast Imaging

July 7, 2026 — QT Imaging Holdings, Inc. recently announced it has successfully completed its first routine inspection ...

Time July 07, 2026
arrow
News | MRI Breast

July 2, 2026 – Quibim has announced the European and UK launch of QP-Breast, its CE and UKCA-marked AI tool which ...

Time July 02, 2026
arrow
News | Mammography

June 30, 2026 — The Food and Drug Administration has cleared new contrast-enhanced mammography (CEM) and CEM biopsy ...

Time June 30, 2026
arrow
News | Mammography

June 23, 2026 — Using artificial intelligence (AI), researchers found that image-based risk scores for breast cancer ...

Time June 24, 2026
arrow
News

May 21, 2026 – Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 22, 2026
arrow
News | FDA

May 6, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 07, 2026
arrow
News | Breast Imaging

April 15, 2026 — QT Imaging Holdings, Inc. has launched its QTI Imaging-Olea Viewer, developed in collaboration with ...

Time April 15, 2026
arrow
News | Breast Imaging

April 1, 2026 — QT Imaging Holdings has released its latest image reconstruction software update, version 4.5.0. This ...

Time April 02, 2026
arrow
News | Ultrasound Imaging

March 30, 2026 — Butterfly Network, Inc. has received clearance from the U.S. Food and Drug Administration (FDA) for a ...

Time April 01, 2026
arrow
News | Breast Imaging

March 30, 2026 — Each year, the Alumni Association at the University of Missouri-Kansas City, recognizes the ...

Time March 31, 2026
arrow
Subscribe Now